Table 3.

Results of the ordinal regression model for post-COVID-19 acute phase substance use among 993 individuals who had mild COVID-19 in São Caetano do Sul, SP, Brazil.

Outcome: post-COVID acute phase ASSIST frequency score	Alcohol			Tobacco			Cannabis			Non-medical benzodiazepine			Non-medical analgesic
	Coef.	95%CI		Coef.	95%CI		Coef.	95%CI		Coef.	95%CI		Coef.	95%CI
Exposures:
Number of CDC COVID-19 symptoms	−0.190	−0.450	0.069	−0.043	−0.199	0.112	−0.149	−0.389	0.091	0.035	−0.129	0.200	−0.053	−0.118	0.012
Pre-COVID-19 alcohol use	1.445***	1.296	1.593	−0.089	−0.321	0.143	0.025	−0.373	0.423	0.024	−0.239	0.287	0.138**	0.046	0.231
Pre-COVID-19 tobacco use	−0.002	−0.075	0.072	1.276***	1.100	1.452	0.047	−0.172	0.266	−0.075	−0.345	0.194	0.022	−0.056	0.100
Pre-COVID-19 cannabis use	0.020	−0.122	0.162	0.080	−0.140	0.299	1.730***	1.372	2.088	−0.648*	−1.169	−0.127	0.039	−0.121	0.199
Pre-COVID-19 non-medical benzodiazepines use	−0.100	−0.293	0.092	−0.005	−0.290	0.279	−0.611*	−1.147	−0.075	1.684***	1.380	1.989	0.179*	0.016	0.343
Pre-COVID-19 non-medical analgesics use	−0.111	−0.214	−0.007	−0.094	−0.296	0.109	0.314*	0.011	0.617	0.399**	0.159	0.639	1.413***	1.285	1.541

All the models adjusted for gender, age, city suburb, civil status, educational level, income, previous medical diseases, previous psychiatric disorder, time between intake and assessment.

^*p < 0.05;

^**p < 0.01;

^***p < 0.001.